888 related articles for article (PubMed ID: 18520599)
1. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of mycophenolic acid and its glucuronidated metabolites in stable lung transplant recipients.
Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
Ann Pharmacother; 2006 Sep; 40(9):1509-16. PubMed ID: 16882870
[TBL] [Abstract][Full Text] [Related]
3. Concentrations of mycophenolic acid and glucuronide metabolites under concomitant therapy with cyclosporine or tacrolimus.
Patel CG; Harmon M; Gohh RY; Akhlaghi F
Ther Drug Monit; 2007 Feb; 29(1):87-95. PubMed ID: 17304155
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the crossreactivity of mycophenolic acid glucuronide metabolites and of mycophenolate mofetil in the Cedia MPA assay.
Shipkova M; Schütz E; Besenthal I; Fraunberger P; Wieland E
Ther Drug Monit; 2010 Feb; 32(1):79-85. PubMed ID: 20042920
[TBL] [Abstract][Full Text] [Related]
5. Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation.
Mino Y; Naito T; Matsushita T; Otsuka A; Ushiyama T; Ozono S; Hishida A; Kagawa Y; Kawakami J
Ther Drug Monit; 2008 Dec; 30(6):656-61. PubMed ID: 18978521
[TBL] [Abstract][Full Text] [Related]
6. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate pharmacokinetics in early period following lung or heart transplantation.
Ensom MH; Partovi N; Decarie D; Ignaszewski AP; Fradet GJ; Levy RD
Ann Pharmacother; 2003 Dec; 37(12):1761-7. PubMed ID: 14632536
[TBL] [Abstract][Full Text] [Related]
8. Comparison of pharmacokinetics of mycophenolic acid and its metabolites between living donor liver transplant recipients and deceased donor liver transplant recipients.
Shen B; Chen B; Zhang W; Mao H; Shen C; Deng X; Zhan X; Chen H
Liver Transpl; 2009 Nov; 15(11):1473-80. PubMed ID: 19877254
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of mycophenolic acid and its 2 glucuronidated metabolites in kidney transplant recipients.
Sam WJ; Akhlaghi F; Rosenbaum SE
J Clin Pharmacol; 2009 Feb; 49(2):185-95. PubMed ID: 19179297
[TBL] [Abstract][Full Text] [Related]
10. Impact of calcineurin inhibitors on urinary excretion of mycophenolic acid and its glucuronide in kidney transplant recipients.
Naito T; Mino Y; Otsuka A; Ushiyama T; Ito T; Ozono S; Kagawa Y; Kawakami J
J Clin Pharmacol; 2009 Jun; 49(6):710-8. PubMed ID: 19451405
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine alters correlation between free and total mycophenolic acid in kidney transplant recipients in the initial phase.
Mino Y; Naito T; Otsuka A; Takayama T; Ozono S; Kagawa Y; Kawakami J
J Clin Pharm Ther; 2011 Apr; 36(2):217-24. PubMed ID: 21366651
[TBL] [Abstract][Full Text] [Related]
12. Effect of t-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of mycophenolate mofetil.
Jain AB; Hamad I; Zuckerman S; Zhang S; Warty VS; Fung JJ; Venkataramanan R
Liver Transpl Surg; 1999 Mar; 5(2):101-6. PubMed ID: 10071348
[TBL] [Abstract][Full Text] [Related]
13. High-performance liquid chromatography-mass spectroscopy/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites.
Figurski MJ; Korecka M; Fields L; Waligórska T; Shaw LM
Ther Drug Monit; 2009 Dec; 31(6):717-26. PubMed ID: 19809389
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil.
Beckebaum S; Armstrong VW; Cicinnati VR; Streit F; Klein CG; Gerken G; Paul A; Oellerich M
Ther Drug Monit; 2009 Apr; 31(2):205-10. PubMed ID: 19307937
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of mycophenolic acid and its glucuronidated metabolites in stable islet transplant recipients.
Al-Khatib M; Shapiro RJ; Partovi N; Ting LS; Ensom MH
Ther Drug Monit; 2010 Jun; 32(3):373-8. PubMed ID: 20357699
[TBL] [Abstract][Full Text] [Related]
16. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
17. Influence of renal insufficiency on pharmacokinetics of ACYL-glucuronide metabolite of mycophenolic acid in renal transplant patients.
González-Roncero FM; Govantes MA; Chaves VC; Palomo PP; Serra MB
Transplant Proc; 2007 Sep; 39(7):2176-8. PubMed ID: 17889129
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine concentration-dependent increase in concentration ratio of mycophenolic acid acyl and phenol glucuronides to mycophenolic acid in stable kidney transplant recipients.
Mino Y; Naito T; Otsuka A; Ushiyama T; Ozono S; Kagawa Y; Kawakami J
Clin Biochem; 2009 May; 42(7-8):595-601. PubMed ID: 19100248
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetic impact of UDP-glucuronosyltransferase metabolic pathway and multidrug resistance-associated protein 2 transport pathway on mycophenolic acid in thoracic transplant recipients: an exploratory study.
Ting LS; Benoit-Biancamano MO; Bernard O; Riggs KW; Guillemette C; Ensom MH
Pharmacotherapy; 2010 Nov; 30(11):1097-108. PubMed ID: 20973683
[TBL] [Abstract][Full Text] [Related]
20. Chronopharmacokinetics of mycophenolic acid and its glucuronide and acyl glucuronide metabolites in kidney transplant recipients converted from cyclosporine to everolimus.
Tedesco-Silva H; Felipe CR; Slade A; Schmouder RL; Medina Pestana JO
Ther Drug Monit; 2012 Dec; 34(6):652-9. PubMed ID: 23131696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]